To study the effect of Dashamoola Siddha Taila Matrabasti and Uttarbasti in the management of Mootraghata W.S.R. to Benign Prostatic Hyperplasia

Efficacy of Dashamoola Siddha Taila Matrabasti And Uttarbasti in the management of Mootraghata W.S.R. To Benign Prostatic Hyperplasia - An Open Labelled Randomized Comparative Clinical Trial

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043639

Enrollment

Registered

2022-07-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with classical signs and symptoms of Mootraghata/BPH like Incomplete emptying, Increased Frequency, Intermittency, Urgency, Weak stream,Straining, Nocturia, Painful mituration, Burning micturition 2. Male patient Age between 40-80 year 3. Controlled case of Diabetes mellitus (RBS upto 180 mg/dl) and Hypertension (upto 150/90 mm Hg)

Exclusion criteria

Exclusion criteria: 1. CA Prostate 2. Urethral stricture 3. Benign tumour of urethra 4. Malignant tumour of urethra 5. Urethral injury, urethral calculi 6. Age above 80 years and below 40 years 7. Patients with systemic diseases like uncontrolled Hypertension (more than 150/90 mm Hg) and uncontrolled Diabetes mellitus (RBS more than 180 mg/dl),Tuberculosis, VDRL, STD, HIV, HBsAg 8. Known case of heart disease 9. According Ayurveda point of view, Matrabasti should not be administered in the persons having Ajirna and who has slept during day time

Design outcomes

Primary

Measure	Time frame
Result will be assased on the basis of relief sign and symptoms of Mootraghata ResultDescription Subjective Criteria :- International Prostate Symptom Score (IPSS) Objective Criteria :- Prostatic size (volume) Urine Flow Rate Residual Urine Volume Timepoint: 21 Days	—

Secondary

Measure	Time frame
Comparing the effect of both procedures in the management of Mootraghata Result Description: Complete cure - 100% relief in subjective, objective findings and IPSS parameters Maximum improvement - 76% to 100% relief in subjective, objective findings and IPSS parameters Moderate improvement - 51% to 75% relief in subjective, objectivefindings and IPSS parameters Mild improvement - 26% to 50% relief in subjective, objective findings and IPSS parameters Unchanged - Up to 25% relief in subjective, objectivefindings and IPSS parametersTimepoint: 2 weeks	—

Measure

Time frame

Comparing the effect of both procedures in the management of Mootraghata Result Description: Complete cure - 100% relief in subjective, objective findings and IPSS parameters Maximum improvement - 76% to 100% relief in subjective, objective findings and IPSS parameters Moderate improvement - 51% to 75% relief in subjective, objectivefindings and IPSS parameters Mild improvement - 26% to 50% relief in subjective, objective findings and IPSS parameters Unchanged - Up to 25% relief in subjective, objectivefindings and IPSS parametersTimepoint: 2 weeks

—

Countries

India

Contacts

Public ContactDr Harshit Shah

Government Akhandanand Ayurved College Ahmedabad

akhandanandprincipal@gmail.com9824068760

Outcome results